Posts Tagged ‘2018’
Pain Management Therapeutics Market Segment Upto 2018: Transparency Market Research
Albany, New York (PRWEB) September 30, 2014
The market of pain management therapeutics aims at producing drugs to alleviate acute as well as chronic pain conditions, thus improving the quality of life of patients. Body pain affects a major portion of the global population, wherein it prevails for varying lengths of time and occurs in a variety of levels. Body pain is a major concern across the globe due its deliberating effects on work productivity.
Pain management therapeutics presently encompasses a variety of pain management therapeutics methods, such as physiotherapy, chiropractor therapy, and the use of minimally invasive pain management devices. However, analgesics or painkillers are commonly prescribed by physicians as the first line of treatment for managing body pain. Drugs from a variety of therapeutic classes, such as antidepressants, opioids, anticonvulsants, anti-migraine agents, non-steroidal anti-inflammatory drugs (NSAIDs), and others are included in the market.
Browse Full Global Pain Management Therapeutics Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/pain-management-therapeutics.html
The global demand for such drugs is very high; in the year 2011, the global pain management therapeutics market had a net worth of US$ 40.93 billion. However, patent expiries of bestselling drugs such as Pfizer, Inc.’s Lyrica (pregabalin) and Eli Lilly & Co.’s Cymbalta (duloxetine) in the near future could lead to a drastic downward trend to the global pain therapeutics market. Declining at a year-on-year rate of 5.5% in the next few years, this market could reach a net worth of US$ 29.47 billion by 2018.
Other than significant reduction in revenues, the loss of market exclusivity of these major revenue-grossing drugs will allow generic drug companies to launch their own versions of these drugs. The global pain management therapeutics market is also affected by the lack of novel drug formulations, which would further account for the declining position of this market.
Other key brands such as Lidoderm (lidocaine), OxyContin (oxycodone), and Cymbalta (duloxetine) are scheduled to lose patent exclusivity in 2013, adding to the negative impact on the growth of the global pain management therapeutics market. However, the market will continue to cater to a large portion of its end users through the segment of OTC drugs, triggered at common body pain conditions.
Segmentation
Amongst the various drug segments covered by the pain management therapeutics market, the segment of NSAIDs is the major revenue generator of the market. Owing to the presence of most popular over the counter painkillers such as ibuprofen, aspirin and diclofenac in this class of drugs, NSAIDs grossed the maximum industry shares of the global pain management therapeutics market in 2011.
By indication, the segments of neuropathic pain and cancer pain earned the leading positions in the global pain management therapeutics market. The major reason behind this is the rising prevalence of conditions such as diabetes and cancer across the globe. As compared to branded formulations, the demand for generic drugs was high in the overall pain management therapeutics market in 2011.
North America stood as the largest regional market of the global pain management therapeutics market due to the presence of one or more branded drugs in the market. However, patent expiries of these brands could suppress growth of this regional market in the near future.
The market for branded drugs was observed to be highly fragmented in the same year, with big companies such as Eli Lilly & Co., Purdue Pharma LP, and Pfizer amassing nearly 80% shares of the total market revenues.
For further inquiries, ask here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1059
Foreword
Though the market is estimated to go through a phase of significant slowdown in the next few years, some favorable healthcare and regulatory reforms such as the U.S. Patient Protection and Affordable Care Act of 2010, and the economic nature of these drugs will continue to drive uptake in the pain management therapeutics market. These drugs are also found to have better effect on body pain than other therapeutic modes such as acupuncture and neurostimulation devices.
Related & Recently Published Reports by Transparency Market Research
Hospital Acquired Pneumonia Drugs Market: According to a new market report published by Transparency Market Research “Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020″ six phase III drugs would generate total revenue of USD 3.8 billion by 2020. Browse full report with TOC: http://www.transparencymarketresearch.com/hospital-acquired-pneumonia-drugs.html
Global and China Insulin Market: The global insulin market was valued at USD 19.99 billion in 2012 and is expected to grow at a CAGR of 6.1% from 2013 to 2019 to reach USD 32.24 billion in 2019. Browse full report with TOC: http://www.transparencymarketresearch.com/insulin-market.html
Contact:
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA/Canada Toll Free: 866-552-3453
Email: sales(at)transparencymarketresearch(dot)com
Web: http://www.transparencymarketresearch.com/
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Food Emulsifier’s Market to reach $ 2,858.6 Million By 2018 – New Report by MarketsandMarkets
(PRWEB) June 20, 2013
The report, “Food Emulsifiers Market By Types (Mono-, Di-Glycerides and Derivatives, Lecithin, Sorbitan Esters, Stearoyl Lactylates and Others), Applications (Bakery & Confectionery, Convenience Foods, Dairy Products, Meat Products and Others) and Geography – Global Trends and Forecast To 2018″, forecasts that the food emulsifiers market will grow from estimated $ 2,108.9 million in 2012 to $ 2,858.6 million by 2018 with a CAGR of 5.2% from 2013 to 2018. Europe led the global market followed by North America and Asia-Pacific in terms of revenue in the year 2012.
Browse:
177 Market Data Tables
35 Figures
335 Pages and an in-depth Table of Content on “Food Emulsifiers Market”
http://www.marketsandmarkets.com/Market-Reports/food-emulsifiers-market-972.html
Early buyers will receive 10% customization on this report.
An emulsifier is a substance that stabilizes an emulsion. Emulsifiers can be used in variety of food segments such as bakery & confectionery, dairy, beverages, convenience foods, and in meat products to manufacture low calorific products. Emulsifiers are used by major food & beverage manufacturers as a food additive for reducing the fat content.
The deskbound lifestyles have resulted in rising needs for convenience foods. However, the alarming rises in health issues faced by consumers have also made them aware about the need to focus on healthy and nutritive convenience food products. The need to minimize the intake of fats and calories influences the demand for specific functional food variants. Emulsifiers are considered to be one of the additives that are gradually replacing many for reducing the fat content in foodstuffs.
Mono-, Di-glycerides & derivatives: Major type of food emulsifier
In 2012, natural emulsifiers accounted for about one-third of the total emulsifier market, whereas synthetic emulsifiers held the rest. Among the synthetic segment, Mono-, Di-glycerides & derivatives constitute the largest share and are expected to grow at a modest pace. Lecithin held a major market in natural emulsifiers and is expected to grow at modest CAGR. Other synthetic emulsifier’s which comprises of polyglycerol esters, sucrose esters and Polyglycerol Polyricinoleate (PGPR), is expected to drive the market for emulsifiers. However, palm oil & other vegetable oil prices are highly volatile and ascertaining accurate future prices would be difficult.
Europe: Largest market for food emulsifiers
Europe generated maximum revenue in global food emulsifier market. U.S., however, is the leader in the segment in the global market. North America, hence, is the second largest market of the segment. China drives the Asia-Pacific market with highest CAGR globally. Germany generated maximum revenue in European market, followed by Italy. ROW emulsifier market, led by Brazil, is also given a boost by the promising growth in South Africa and Middle East.
Bakery & confectionery: Biggest market by applications
Further, the application of modern food processing techniques is driving the expansion of food production and new product development in diverse segments such as dairy, bakery, confectionery, processed foods, fats, as well as oils; and this is likely to spur the growth of the food emulsifiers markets. Governments worldwide are developing policies and regulations to penalize unhealthy diets and support healthy ones.
The report also touches on various other important aspects of the market. It includes Porter’s analysis, the competitive landscape, a price analysis and the patent analysis. In addition, 19 key players of this market have also been profiled.
Buy a copy of this report @ http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=972.
Find related Reports to – Food and Beverage.
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Contact:
Mr. Rohan
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Connect with us on LinkedIn
Connect with us on Facebook
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Related Derivatives Press Releases